or Try an Advanced Search...

    Technical Analysis for TNYA - Tenaya Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 4.51 -2.17% -0.10
    TNYA closed down 2.17 percent on Wednesday, May 8, 2024, on 37 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical TNYA trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Earnings Movers Other 0.00%
    Inside Day Range Contraction 0.00%
    20 DMA Support Bullish -2.17%
    Pocket Pivot Bullish Swing Setup -2.17%
    Bollinger Band Squeeze Range Contraction -2.17%
    Bollinger Band Squeeze Range Contraction -0.66%
    BB Squeeze + Upper Band Touch Range Contraction -0.66%
    Older End-of-Day Signals for TNYA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 14 hours ago
    Possible Inside Day about 14 hours ago
    10 DMA Support about 18 hours ago
    Down 2 % about 19 hours ago
    Down 1% about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TNYA Chart by TradingView
    Basic chart:

    Profile

    Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was incorporated in 2016 and is based in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Gene Therapy Heart Failure Biomarkers Heart Disease Induced Stem Cells Personalized Medicine Chemical Pathology

    Is TNYA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 2 Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
    Apr 14 Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company
    Mar 26 20 Countries with the Highest Heart Disease Deaths Per Capita
    Mar 20 Tenaya Therapeutics Inc Reports Full Year and Q4 2023 Financial Results
    Mar 18 Tenaya Therapeutics GAAP EPS of -$0.40 beats by $0.04
    Mar 18 Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    Mar 18 Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
    Mar 15 Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
    Feb 29 14 Stocks With Heavy Insider Buying In 2024
    Feb 27 Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
    See more TNYA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.09
    52 Week Low 1.66
    Average Volume 440,591
    200-Day Moving Average 3.69
    50-Day Moving Average 4.96
    20-Day Moving Average 4.48
    10-Day Moving Average 4.53
    Average True Range 0.30
    RSI (14) 47.09
    ADX 11.61
    +DI 21.30
    -DI 18.39
    Chandelier Exit (Long, 3 ATRs) 4.05
    Chandelier Exit (Short, 3 ATRs) 4.88
    Upper Bollinger Bands 4.75
    Lower Bollinger Band 4.20
    Percent B (%b) 0.56
    BandWidth 12.27
    MACD Line -0.06
    MACD Signal Line -0.10
    MACD Histogram 0.0436
    Fundamentals Value
    Market Cap 307.18 Million
    Num Shares 68.1 Million
    EPS -1.86
    Price-to-Earnings (P/E) Ratio -2.42
    Price-to-Sales 0.00
    Price-to-Book 2.12
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.68
    Resistance 3 (R3) 4.69 4.64 4.65
    Resistance 2 (R2) 4.64 4.60 4.64 4.64
    Resistance 1 (R1) 4.58 4.58 4.56 4.57 4.63
    Pivot Point 4.53 4.53 4.52 4.53 4.53
    Support 1 (S1) 4.47 4.49 4.45 4.46 4.39
    Support 2 (S2) 4.42 4.47 4.42 4.38
    Support 3 (S3) 4.36 4.42 4.37
    Support 4 (S4) 4.35